Innovating Healthcare Our Story
Q2 Clinical Research (Q2CR) is an innovative and trailblazing consultancy service provider in the field of clinical research, making significant strides in the healthcare industry. Our office is situated in Ahmedabad, Gujarat, and we extend our services globally, led by a team of passionate professionals committed to serving humanity.
Drawing on our extensive industry knowledge, we specialize in facilitating a wide array of studies, including patient-based BA-BE studies and clinical trials that encompass phases II to IV. Our expertise covers diverse study designs and therapeutic areas, enabling us to navigate a broad spectrum of medical indications.
At Q2 Clinical Research (Q2CR), we place utmost importance on quality and ethical standards. Rigorous Quality Control measures are our top priority, and we excel in conducting clinical audits, continuously striving to achieve the highest benchmarks of quality.
Join us in our noble mission to elevate healthcare standards and make a positive impact on the well-being of individuals worldwide. Together, let’s shape the future of healthcare and contribute to a healthier and happier world.
Dr. Jignesh Patel
(M.Pharm., PhD, CRM, CCP)
Chief Executive Office
Q2 Clinical Research
Phone: +91 99780 67027
Email: jignesh.patel@q2cr.com
- Dr.Jignesh Patel is pharmaceutical scientist with having more than 20 years of industrial experience in pharmaceutical research contributing to >100 therapeutic products in market treating >1 lakh patients every year.
- He has done his bachelor & master in pharmacy from L.M.College of Pharmacy (LMCP), and PhD in Pharmacology under the guidance of Dr.R.K.Goyal, Professor at LMCP and Ex-vice-chancellor of M.S.University, Vadodara. He has done various clinical pharmacology courses from NIH, USA.
- He had published >40 articles in various scientific journals indexed in Pubmed, Scopus etc.
- He has received many national and international awards of US$2200, Rs.131000, US$500 from UK, USA, Australia etc. for his research work and scientific publications.
- He had worked with India’s top pharmaceutical industry, Sun Pharma’s R & D Centre, Vadodara for 10 years as “In-charge of Phase 1 clinical trial unit”. Dr.Jignesh is pioneer of setting up India’s first phase 1 clinical trial unit of Sun Pharma in 2008. He is also the pioneer of setting up India’s dedicated first Phase 1 clinical trial unit & Pharmacodynamics Labs of CBCC Global Research, India & USA in 2018.
- He has directly led clinical development of more than 10 New Medicines INDs for USFDA, more than 14 NDDS, 37 medical devices, 3 Biosimilars, 2 vaccines & more than 140 generic products for USFDA, EMA, MHRA and other regulatory market. During his early career, he has worked at various hospitals and has handled clinical trials of global pharma industries including Sanofi, GSK, Pfizer, BMS, Boehringer Ingelheim, J & J, Medtronic, AstraZeneca, Novartis etc. for global clinical trial in Europe and UK hospital sites.
- He has handled more than 50 regulatory audits for clinical trials from USFDA, EMA, MHRA, CDSCO, ANVISA, Malaysia Regulatory Authority.
Vision
- To be a global center of excellence in Clinical Research consultancy services.
- Bridging Science and Compassion for Patient Well-being
Mission
- We are dedicated to delivering unparalleled industry services, characterized by the utmost quality and accurate data.
- Our aim is to foster transformation, technology, and innovation through training, research, and development.
- We are dedicated to nurturing and empowering talents to drive organizational growth and excellence.
Values
- Professionalism
- Quality
- Teamwork
- Commitment
- Results delivered within specified timeframes
Quality and Compliance
At Q2 Clinical Research (Q2CR), we are deeply committed to upholding the highest standards of quality and compliance in clinical research. We prioritize the following key aspects:
- Adherence to Good Clinical Practice (GCP) Guidelines: We strictly adhere to the principles and guidelines outlined in Good Clinical Practice.
- Compliance with Regulatory Requirements: We meticulously adhere to all relevant regulatory requirements, both at the national and international levels.
- Quality Control Measures: Quality is of utmost importance to us. We have implemented stringent quality control measures at every stage of our research operations.
We establishes a solid foundation for conducting research with the utmost integrity and precision. Our commitment to quality and compliance ensures that the data generated from our studies is reliable, ethical, and can be trusted by regulatory authorities, sponsors, and the broader scientific community.
